Shannon Lange1,2, Charlotte Probst1,3, Gerrit Gmel1,4, Jürgen Rehm1,2,3,5,6, Larry Burd7, Svetlana Popova1,2,5,8. 1. Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 2. Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 3. Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, Technische Universität Dresden, Dresden, Germany. 4. School of Electrical Engineering and Telecommunications, Faculty of Engineering, University of New South Wales, Sydney, Australia. 5. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 6. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 7. Department of Pediatrics, University of North Dakota School of Medicine, Grand Forks. 8. Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Ontario, Canada.
Abstract
Importance: Prevalence estimates are essential to effectively prioritize, plan, and deliver health care to high-needs populations such as children and youth with fetal alcohol spectrum disorder (FASD). However, most countries do not have population-level prevalence data for FASD. Objective: To obtain prevalence estimates of FASD among children and youth in the general population by country, by World Health Organization (WHO) region, and globally. Data Sources: MEDLINE, MEDLINE in process, EMBASE, Education Resource Information Center, Cumulative Index to Nursing and Allied Health Literature, Web of Science, PsychINFO, and Scopus were systematically searched for studies published from November 1, 1973, through June 30, 2015, without geographic or language restrictions. Study Selection: Original quantitative studies that reported the prevalence of FASD among children and youth in the general population, used active case ascertainment or clinic-based methods, and specified the diagnostic guideline or case definition used were included. Data Extraction and Synthesis: Individual study characteristics and prevalence of FASD were extracted. Country-specific random-effects meta-analyses were conducted. For countries with 1 or no empirical study on the prevalence of FASD, this indicator was estimated based on the proportion of women who consumed alcohol during pregnancy per 1 case of FASD. Finally, WHO regional and global mean prevalence of FASD weighted by the number of live births in each country was estimated. Main Outcomes and Measures: Prevalence of FASD. Results: A total of 24 unique studies including 1416 unique children and youth diagnosed with FASD (age range, 0-16.4 years) were retained for data extraction. The global prevalence of FASD among children and youth in the general population was estimated to be 7.7 per 1000 population (95% CI, 4.9-11.7 per 1000 population). The WHO European Region had the highest prevalence (19.8 per 1000 population; 95% CI, 14.1-28.0 per 1000 population), and the WHO Eastern Mediterranean Region had the lowest (0.1 per 1000 population; 95% CI, 0.1-0.5 per 1000 population). Of 187 countries, South Africa was estimated to have the highest prevalence of FASD at 111.1 per 1000 population (95% CI, 71.1-158.4 per 1000 population), followed by Croatia at 53.3 per 1000 population (95% CI, 30.9-81.2 per 1000 population) and Ireland at 47.5 per 1000 population (95% CI, 28.0-73.6 per 1000 population). Conclusions and Relevance: Globally, FASD is a prevalent alcohol-related developmental disability that is largely preventable. The findings highlight the need to establish a universal public health message about the potential harm of prenatal alcohol exposure and a routine screening protocol. Brief interventions should be provided, where appropriate.
Importance: Prevalence estimates are essential to effectively prioritize, plan, and deliver health care to high-needs populations such as children and youth with fetal alcohol spectrum disorder (FASD). However, most countries do not have population-level prevalence data for FASD. Objective: To obtain prevalence estimates of FASD among children and youth in the general population by country, by World Health Organization (WHO) region, and globally. Data Sources: MEDLINE, MEDLINE in process, EMBASE, Education Resource Information Center, Cumulative Index to Nursing and Allied Health Literature, Web of Science, PsychINFO, and Scopus were systematically searched for studies published from November 1, 1973, through June 30, 2015, without geographic or language restrictions. Study Selection: Original quantitative studies that reported the prevalence of FASD among children and youth in the general population, used active case ascertainment or clinic-based methods, and specified the diagnostic guideline or case definition used were included. Data Extraction and Synthesis: Individual study characteristics and prevalence of FASD were extracted. Country-specific random-effects meta-analyses were conducted. For countries with 1 or no empirical study on the prevalence of FASD, this indicator was estimated based on the proportion of women who consumed alcohol during pregnancy per 1 case of FASD. Finally, WHO regional and global mean prevalence of FASD weighted by the number of live births in each country was estimated. Main Outcomes and Measures: Prevalence of FASD. Results: A total of 24 unique studies including 1416 unique children and youth diagnosed with FASD (age range, 0-16.4 years) were retained for data extraction. The global prevalence of FASD among children and youth in the general population was estimated to be 7.7 per 1000 population (95% CI, 4.9-11.7 per 1000 population). The WHO European Region had the highest prevalence (19.8 per 1000 population; 95% CI, 14.1-28.0 per 1000 population), and the WHO Eastern Mediterranean Region had the lowest (0.1 per 1000 population; 95% CI, 0.1-0.5 per 1000 population). Of 187 countries, South Africa was estimated to have the highest prevalence of FASD at 111.1 per 1000 population (95% CI, 71.1-158.4 per 1000 population), followed by Croatia at 53.3 per 1000 population (95% CI, 30.9-81.2 per 1000 population) and Ireland at 47.5 per 1000 population (95% CI, 28.0-73.6 per 1000 population). Conclusions and Relevance: Globally, FASD is a prevalent alcohol-related developmental disability that is largely preventable. The findings highlight the need to establish a universal public health message about the potential harm of prenatal alcohol exposure and a routine screening protocol. Brief interventions should be provided, where appropriate.
Authors: Claire D Coles; Amanda R Gailey; Jennifer G Mulle; Julie A Kable; Mary Ellen Lynch; Kenneth Lyons Jones Journal: Alcohol Clin Exp Res Date: 2016-03-29 Impact factor: 3.455
Authors: Philip A May; Amy Baete; Jaymi Russo; Amy J Elliott; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; Omar Abdul-Rahman; Margaret P Adam; Luther K Robinson; Melanie Manning; H Eugene Hoyme Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Betty A Poitra; Shirley Marion; Marilyn Dionne; Esther Wilkie; Paul Dauphinais; Marma Wilkie-Pepion; John T Martsolf; Marilyn G Klug; Larry Burd Journal: Neurotoxicol Teratol Date: 2003 Nov-Dec Impact factor: 3.763
Authors: Philip A May; Daniela Fiorentino; Giovanna Coriale; Wendy O Kalberg; H Eugene Hoyme; Alfredo S Aragón; David Buckley; Chandra Stellavato; J Phillip Gossage; Luther K Robinson; Kenneth Lyons Jones; Melanie Manning; Mauro Ceccanti Journal: Int J Environ Res Public Health Date: 2011-06-22 Impact factor: 3.390
Authors: Mary Jane Rotheram-Borus; Kodi B Arfer; Joan Christodoulou; W Scott Comulada; Jacqueline Stewart; Julia E Tubert; Mark Tomlinson Journal: J Consult Clin Psychol Date: 2019-06
Authors: Xiaojie Wang; Verginia C Cuzon Carlson; Colin Studholme; Natali Newman; Matthew M Ford; Kathleen A Grant; Christopher D Kroenke Journal: Proc Natl Acad Sci U S A Date: 2020-04-20 Impact factor: 11.205
Authors: Krista D Sowell; Roberta R Holt; Janet Y Uriu-Adams; Christina D Chambers; Claire D Coles; Julie A Kable; Lyubov Yevtushok; Natalya Zymak-Zakutnya; Wladimir Wertelecki; Carl L Keen Journal: J Am Coll Nutr Date: 2020-04-02 Impact factor: 3.169